Pharmacological insights from P-glycoprotein knockout mice

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 1, 1998, Pages 9-13

  Schinkel, A H ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Blood brain barrier; Drug disposition; Multidrug resistance; P glycocoprotein; Pharmacokinetics

Indexed keywords

ANTINEOPLASTIC AGENT; GLYCOPROTEIN P;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD; BLOOD BRAIN BARRIER; CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG METABOLISM; DRUG TRANSPORT; INTESTINE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHYSIOLOGY; PROTEIN DEFICIENCY; TUMOR CELL;

ANIMALS; DRUG RESISTANCE, MULTIPLE; GENES, MDR; MICE; MICE, KNOCKOUT; P-GLYCOPROTEIN;

EID: 0031982725     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Arceci RJ, Croop JM, Horwitz SB, Housman D 1988 The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci USA 85: 4350-4354
2. Borst P, Schinkel AH 1997 Genetic dissection of the function of mammalian P-glycoproteins. Trends Genet 13: 217-222
3. Chaudhary PM, Roninson IB 1991 Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66: 85-95
4. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR 1989 Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86: 695-698
5. Croop JM, Raymond M, Haber D, Devault A, Arceci RJ, Gros P, Housman DE 1989 The three mouse multidrug resistance (mdr) genes are expressed in a tissue specific manner in normal mouse tissues. Mol Cell Biol 9: 1346-1350
6. Devault A, Gros P 1990 Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol 10: 1652-1663
7. Endicott JA, Ling V 1989 The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171
8. Gottesman MM, Pastan I 1993 Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427
9. Gros P, Croop J, Housman D 1986 Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47: 371-380
10. Higgins CF, Gottesman MM 1992 Is the multidrug transporter a flippase? Trends Biochem Sci 17: 18-21
11. Hsu SI-H, Lothstein L, Horwitz SB 1989 Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. J Biol Chem 264: 12053-12062
12. Klimecki WT, Futscher BW, Grogan TM, Dalton WS 1994 P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83: 2451-2458
13. Mayer U, Wagenaar E, Beijnen JH, Smit JW, Meijer DKF, van Asperen J, Borst P, Schinkel AH 1996 Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein. Br J Cancer 119: 1038-1044
14. Roninson IB 1992 The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol 43: 95-102
15. Ruetz S, Gros P 1994 A mechanism for P-glycoprotein action in multidrug resistance: are we there yet? Trends Pharmacol Sci 15: 260-263
16. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus Maandag EC, te Riele HPJ, Berns AJM, Borst P 1994 Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502
17. Schinkel AH, Wagenaar E, van Deemter L, Mol CAAM, Borst P 1995 Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J Clin Invest 96: 1698-1705
18. Schinkel AH, Wagenaar E, Mol CAAM, van Deemter L 1996 P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97: 2517-2524
19. Schinkel AH, Mayer U, Wagenaar E, Mol CAAM, van Deemter L, Smit JJM, van der Valk, MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JMJM, Fibbe WE, Borst P 1997 Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94: 4028-4033
20. Sikic BI 1993 Modulation of multidrug resistance: at the threshold. J Clin Oncol 11: 1629-1635
21. Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DKF, Borst P, Nooijen WJ, Beijnen JH, van Tellingen O 1997 Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 94: 2031-2035
22. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC 1987 Cellular localization of the multidrug resistance gene product in normal human tissues. Proc Natl Acad Sci USA 84: 7735-7738
23. Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y 1981 Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967-1972
24. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R 1992 Human P-glycoprotein transports Cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 267: 24248-24252
25. Van Asperen J, Schinkel AH, Beijnen JH, Nooijen WJ, Borst P, van Tellingen O 1996 Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein-deficient mice. J Natl Cancer Inst 88: 994-999
26. Van Asperen J, van Tellingen O, Sparreboom A, Schinkel AH, Borst P, Nooijen WJ, Beijnen JH 1997 Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. Brit J Cancer in press
27. Wacher VJ, Salphati L, Benet LZ 1996 Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev 20: 99-112